Efficacy of 5% methylene blue photodynamic therapy in the treatment of potentially malignant oral disorders: a randomized, double-blind, controlled trial
de Freitas Silva B, Rocha R, Prudente T, de Oliveira Lenza M, Ferraz D, Mezaiko E, do Couto Lima Moreira F, Yamamoto-Silva F. Efficacy of 5% methylene blue photodynamic therapy in the treatment of potentially malignant oral disorders: a randomized, double-blind, controlled trial. International Journal Of Clinical Trials 2024, 11: 207-214. DOI: 10.18203/2349-3259.ijct20242003.Peer-Reviewed Original ResearchMalignant oral disordersOral leukoplakiaPhotodynamic therapyOral disordersSecondary prevention of oral cancerMethylene blue photodynamic therapyDouble-blind clinical trialPrevention of oral cancerEfficacy of photodynamic therapyMalignant transformation rateAminolevulinic acidTreatment of OLClinical remissionDouble-blindCost of treatmentOral cancerClinical trialsPrimary outcomeSecondary outcomesSecondary preventionTreatment protocolsExtensive lesionsRisk factorsConventional treatmentControlled Trials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply